# Final picks, week of 2026-10-05

Alert window: Monday 2026-10-05 to Friday 2026-10-09 (picks valid 5 trading days). **No picks this week, so alerts have nothing to watch.**

Rules applied (config/strategy.json, unchanged): reward to risk at least 2.0 on the scan's levels, measured as (target - middle of buy zone) / (middle of buy zone - stop); stop no more than 10% below the top of the buy zone; chart not in a downtrend and RSI not above 75; business news OK. Technical and qualitative views weighted 0.5 / 0.5.

## Picks

| Sector | Ticker | Buy zone | Target | Stop | R/R | Source |
|---|---|---|---|---|---|---|
| Technology | none | - | - | - | - | - |
| Health Care | none | - | - | - | - | - |

## Why no pick

The two agents disagreed in both sectors. Neither pick passes the 2.0 reward to risk floor on the levels the scan suggested.

### Technology
- **NVDA (technical pick, score 89.1).** The chart is clean: uptrend, RSI 63.01, MACD above signal. Business numbers are strong too (revenue +105.9%, earnings +127.8%, analyst upside 40.1%, earnings 2026-11-17, outside the window). But the scan's levels (buy 222.63-233.95, target 255.46 at the 1.272 extension, stop 211.06) give R/R **1.58**. The technical agent got to 2.87 only by moving the target to the 1.618 extension (277.81). That is about 19% above today's 233.95, for a pick that lasts five trading days. Choosing the farther target just to clear the rule is stretching, so I did not accept it.
- **MU (qualitative pick).** Buy 1044.59-1074.89, target 1254.81, stop 905.39. R/R is **1.26** and the stop is 15.8% below the buy zone, past the 10% cap. It fails on both counts.
- **Other names that pass 2.0 on scan levels.** Only two in the sector do:
  - APP (4.43): Fib downtrend, technical score 0.0, a fresh class action and analyst downgrades.
  - PDD (2.07): Fib downtrend, technical score 2.1, earnings -11.2% (revenue +8.1%).

  Both fail the chart check.
- Runner-ups don't help either. On scan levels MSFT is 1.47 and AVGO is 0.60.

### Health Care
- **GILD (technical pick).** Scan levels are buy 141.11-144.74, target 154.2 (the swing high), stop 135.69, which gives R/R **1.56**. The 2.85 figure needs the 1.272 extension (163.52), above a swing high the stock hasn't retaken. The chart is also soft (RSI 44.48, MACD below signal), and the business numbers are thin (revenue +10.2%, analyst upside 9.6%).
- **DXCM (qualitative pick).** Buy 84.12-85.36, target 92.59, stop 78.10, which gives R/R **1.18**. It is below its 50-day average and its MACD is under the signal line.
- No Health Care stock in the scan reaches 2.0 on its suggested levels. REGN is the best at 1.51.

## What would make me wrong
- NVDA could run to its 1.618 extension (277.81) this week, and it would have been a good trade. That's possible in a strong tech tape, but you can't plan a 2:1 trade on it. If NVDA pulls back toward 222.63 (the 0.236 retracement) with the trend intact, the R/R on the 255.46 target improves. Next week's scan should catch that.
- Health Care may be bottoming, with GILD and AMGN still in Fib uptrends. If so, sitting out costs a few points of upside. A missed trade costs nothing.

## If you want to trade anyway
These setups fall outside the rules. The rules-based answer is no trade this week. If you still want to trade, the closest candidate is NVDA on the scan's own levels: buy 222.63-233.95, target 255.46, stop 211.06, R/R 1.58. Use a smaller position than usual.

## Update: one-week exception (approved by Top, 2026-10-04)
Top chose to watch NVDA this week even though it misses the 2.0 rule. The strategy file is unchanged (still version 1). Only this week's pick list changed.

| Sector | Ticker | Buy zone | Target | Stop | R/R | Source |
|---|---|---|---|---|---|---|
| Technology | NVDA | 222.63-233.95 | 255.46 | 211.06 | 1.58 | technical |
| Health Care | none | - | - | - | - | - |

All levels are the scan's own suggested levels (data/technical_scan.json). The alerts watch it from Monday 2026-10-05 to Friday 2026-10-09. Use a smaller position than usual. The weekly review should judge this pick as an exception, not as evidence for or against the 2.0 rule.
